The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of blood pressure medications on
cognition and blood flow in hypertensive elderly patients with cognitive impairment. The
hypothesis is that treatment with an angiotensin receptor blocker (ARB) or an
angiotensin-converting enzyme inhibitor (ACEI) will be associated with a slower rate of
further cognitive decline, improved cerebral blood flow and its regulation, and preserved
physical function as compared to treatment with a diuretic (HCTZ), independent of blood
pressure level.
Phase:
Phase 2
Details
Lead Sponsor:
University of Southern California
Collaborators:
Hebrew SeniorLife National Institute on Aging (NIA)